🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 07782B104
- Market Cap
- Mid Cap · $668 Million
- IPO
- 4/29/2022 · $6.00/share
- ADR Ratio
- 1:1
Business: Belite Bio, Inc is a clinical stage biopharmaceutical drug development company focused on novel therapeutics targeting currently untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease.
Company Contact
- CEO
- Yu-Hsin Lin
- CFO
- Hao-Yuan Chuang
- Headquarters
- 5820 Oberlin Drive, Suite 101, San Diego, CA 92121
- Phone
- 858-246-6240
- Investor Relations
- Jennifer Wu · 858-246-6240 · ir@belitebio.com